EconPapers    
Economics at your fingertips  
 

Corporate Social Responsibility and Financial Performance in the Chinese Pharmaceutical Sector: The Roles of Technological Innovation and Media Coverage

Jin Wang, Singha Chaveesuk and Vasu Keerativutisest ()
Additional contact information
Jin Wang: KMITL Business School, King Mongkut’s Institute of Technology Ladkrabang, Bangkok 10520, Thailand
Singha Chaveesuk: KMITL Business School, King Mongkut’s Institute of Technology Ladkrabang, Bangkok 10520, Thailand
Vasu Keerativutisest: KMITL Business School, King Mongkut’s Institute of Technology Ladkrabang, Bangkok 10520, Thailand

Sustainability, 2025, vol. 17, issue 8, 1-22

Abstract: The pharmaceutical industry has been developing rapidly in recent years, and concerns have been widely raised about social responsibility for the safety of people’s lives. This research aims to investigate the impact of CSR on CFP of listed pharmaceutical companies in China. This study was based on the data of pharmaceutical listed companies from 2010 to 2020 as a sample and built regression models for the effects of pharmaceutical corporate social responsibility (CSR) on corporate financial performance (CFP) based on the indirect effects of technological innovation and media coverage. The two-way fixed effect method, the systematic generalized method of moments estimation (SYS-GMM), and the Bootstrap method are adopted for the regression analysis of the model. The research found that (1) CSR positively affected CFP; (2) CSR positively affected technological innovation, while technological innovation partially mediated between CSR and CFP; and (3) both positive and negative media coverage negatively moderated the relationship between CSR and CFP as well as the relationship between CSR and technological innovation. In addition, both positive and negative media coverage negatively moderates the mediation path of “CSR–corporate innovation–CFP”.

Keywords: corporate social responsibility; corporate financial performance; technological innovation; media coverage; Chinese pharmaceutical industry (search for similar items in EconPapers)
JEL-codes: O13 Q Q0 Q2 Q3 Q5 Q56 (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/2071-1050/17/8/3300/pdf (application/pdf)
https://www.mdpi.com/2071-1050/17/8/3300/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jsusta:v:17:y:2025:i:8:p:3300-:d:1630206

Access Statistics for this article

Sustainability is currently edited by Ms. Alexandra Wu

More articles in Sustainability from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-04-09
Handle: RePEc:gam:jsusta:v:17:y:2025:i:8:p:3300-:d:1630206